about
prothrombin -> activated thrombin (factor IIa) + thrombin activation peptide (Xa catalyst)factor V -> factor Va + factor V activation peptidefactor Va + factor Xa -> Va:Xa complex (prothrombinase)prothrombin -> activated thrombin (factor IIa) + thrombin activation peptide (prothrombinase catalyst)fibrinogen -> fibrin monomer + 2 fibrinopeptide A + 2 fibrinopeptide Bn fibrin monomers -> fibrin multimerfactor XIII -> factor XIII cleaved tetramer + 2 factor XIII A activation peptidesfactor XIII cleaved tetramer + 2 Ca++ -> factor XIIIa + 2 factor XIII B chainfibrin multimer -> fibrin multimer; crosslinked + NH4+antithrombin III + heparin -> antithrombin III:heparinactivated thrombin (factor IIa) + antithrombin III:heparin -> thrombin:antithrombin III:heparinthrombin:antithrombin III:heparin -> thrombin:cleaved antithrombin III:heparinthrombin:cleaved antithrombin III:heparin -> thrombin:cleaved antithrombin III + heparinactivated thrombin (factor IIa) + thrombomodulin -> activated thrombin:thrombomodulinPROCR binds Protein CActivated thrombin:thrombomodulin cleaves PROCR:Protein C to PROCR:Activated protein CActivated protein C is released from PROCRActivated protein C binds Protein SActivated protein C cleaves factor Va to factor Vi intermediate formActivated protein C cleaves Factor Va intermediate form for Factor VaActivated protein C cleaves factor VIIIaHeparin cofactor 2 (SERPIND1) binds activated thrombin (factor IIa)Protease nexin-1 (PN1) is a specific and extremely efficient inhibitor of thrombin.SERPINA5 binds activated protein CActivated protein C:PROCR binds F2RSoluble PROCR binds activated protein CSoluble PROCR binds PRTN3:CD177Factor Xa inhibitors binds XaFactor Xa inhibitors bind Va:Xa
P361
Q50291206-C5369126-88CF-4466-A808-C5B4D584819DQ50291207-A1D20D5A-4BC9-4C34-9AD9-F67F155305C6Q50291208-017E7963-82EC-4598-96DA-BE28D19B9503Q50291209-54A4A440-98B3-4798-BE98-89B78C7342C6Q50291210-A248018D-5CEB-4B2A-A8D8-64686C868DB4Q50291211-32F71753-A8FF-49C0-A50E-F627AFB54801Q50291212-F371A006-2243-4869-B9EA-C209C0C4D945Q50291213-6BDCA611-A0A4-4E06-8D97-6CA7F188A025Q50291214-66D46D45-42B2-48A3-8741-CC06585FF809Q50291215-18FE8DFB-982E-486B-9F95-6E26DE22BB6BQ50291216-4675105D-28A2-45A0-A7F3-3F76D4A4AA91Q50291217-074A8BEA-A4FA-497A-A372-16048A5CF1E2Q50291218-57886228-D224-451C-9E22-564F746F7965Q50291220-21612B42-A5F1-4A8C-B8EE-37817CE6D061Q50291222-1010D5B6-F778-4C88-8FA7-1E0501A09D5AQ50291223-DCC743C4-230C-4F3F-AC0D-F34160A94A20Q50291225-88DED035-B68A-4142-8F39-7D979D292ABDQ50291226-39599309-C00F-4B8F-BF46-26EB457653E6Q50291227-321B6FB7-8CF1-44F8-BADE-F99ECA296858Q50291229-0DE55DB0-F818-4867-9F7E-6481497F96E4Q50291230-E156CF80-4410-4B05-97CC-97AF7F4A9612Q50291231-772A5596-E72B-4B5A-94E0-9388A2347E41Q50291232-7FB96CAE-88FF-43F5-8C4A-1282ED72BB4AQ50291233-E9653579-90BD-4CAB-BDD0-5CA01AF1A99FQ50291234-9931A098-CB00-467B-9352-866EAB8FC64BQ50291235-3359A440-3F2C-4A6B-A1B3-B787DA7AE109Q50291236-2142EDD5-2114-4A3C-AE97-F69CF6647F16Q56858685-DA37CDD9-48BC-4A44-BAAD-4481C9E8F910Q56858686-4A08E261-34B7-4458-A826-BA2ED2196988
P361
description
An instance of the biological ...... Clot Formation in Homo sapiens
@en
name
Common Pathway of Fibrin Clot Formation
@en
type
label
Common Pathway of Fibrin Clot Formation
@en
prefLabel
Common Pathway of Fibrin Clot Formation
@en
P527
P3937
R-HSA-140875